Maggie Loughran
Manager, Global Medical Operations, Global Clinical Development Regeneron Pharmaceuticals
Maggie Loughran has six years of experience at Regeneron, where she specializes in supporting Managed Access Programs across all therapeutic areas and driving Real-World Evidence (RWE) generation. She holds a Bachelor of Science in Biology and a Master of Public Health in Epidemiology, which fuel her passion for expanding patient access to innovative therapies and leveraging data for impactful decision-making. Maggie plays a pivotal role in bridging clinical research and patient care.
Seminars
Thursday 26th March 2026
The Role of Compassionate Use & Expanded Access Programs in Epidemics & Pandemics: A Look at COVID-19 & Ebola
11:30 am
- Examine how Compassionate Use and Expanded Access Programs operate in fast-moving outbreaks, using Ebola and COVID-19 to illustrate the clinical, regulatory, and ethical landscape
- Compare two approaches our team deployed in each outbreak, explaining when and why they were chosen, how they were implemented, and their impact on patient access
